Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
García-Martínez E, Gil GL, Benito AC, González-Billalabeitia E, Conesa MA, García García T, García-Garre E, Vicente V, Ayala de la Peña F. García-Martínez E, et al. Among authors: ayala de la pena f. Breast Cancer Res. 2014 Nov 29;16(6):488. doi: 10.1186/s13058-014-0488-5. Breast Cancer Res. 2014. PMID: 25432519 Free PMC article.
On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism.
Carmona-Bayonas A, Font C, Jiménez-Fonseca P, Fenoy F, Otero R, Beato C, Plasencia J, Biosca M, Sánchez M, Benegas M, Calvo-Temprano D, Varona D, Faez L, Vicente MA, de la Haba I, Antonio M, Madridano O, Ramchandani A, Castañón E, Marchena PJ, Martínez MJ, Martín M, Marín G, Ayala de la Peña F, Vicente V; Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia. Carmona-Bayonas A, et al. Among authors: ayala de la pena f, de la haba i. Thromb Res. 2016 Jul;143:76-85. doi: 10.1016/j.thromres.2016.05.010. Epub 2016 May 12. Thromb Res. 2016. PMID: 27208461
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy.
Luengo-Gil G, García-Martínez E, Chaves-Benito A, Conesa-Zamora P, Navarro-Manzano E, González-Billalabeitia E, García-Garre E, Martínez-Carrasco A, Vicente V, Ayala de la Peña F. Luengo-Gil G, et al. Among authors: ayala de la pena f. Cell Oncol (Dordr). 2019 Oct;42(5):627-644. doi: 10.1007/s13402-019-00450-2. Epub 2019 May 21. Cell Oncol (Dordr). 2019. PMID: 31115881
Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results.
Flores-Funes D, Aguilar-Jiménez J, Martínez-Gálvez M, Ibáñez-Ibáñez MJ, Carrasco-González L, Gil-Izquierdo JI, Chaves-Benito MA, Ayala-De La Peña F, Nieto-Olivares A, Aguayo-Albasini JL. Flores-Funes D, et al. Among authors: ayala de la pena f. Surg Oncol. 2019 Sep;30:52-57. doi: 10.1016/j.suronc.2019.05.019. Epub 2019 May 25. Surg Oncol. 2019. PMID: 31500785 Clinical Trial.
Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables.
Ivars Rubio A, Yufera JC, de la Morena P, Fernández Sánchez A, Navarro Manzano E, García Garre E, García Martinez E, Marín Zafra G, Sánchez Cánovas M, García Torralba E, Ayala de la Peña F. Ivars Rubio A, et al. Among authors: de la morena p, ayala de la pena f. Sci Rep. 2019 Nov 18;9(1):16979. doi: 10.1038/s41598-019-53606-3. Sci Rep. 2019. PMID: 31740715 Free PMC article.
Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment.
Flores-Funes D, Aguilar-Jiménez J, Martínez-Gálvez M, Ibáñez-Ibáñez MJ, Carrasco-González L, Gil-Izquierdo JI, Chaves-Benito MA, Ayala-De La Peña F, Nieto-Olivares A, Aguayo-Albasini JL. Flores-Funes D, et al. Among authors: ayala de la pena f. Surg Oncol. 2021 Sep;38:101629. doi: 10.1016/j.suronc.2021.101629. Epub 2021 Jun 18. Surg Oncol. 2021. PMID: 34171793
Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results.
Flores-Funes D, Aguilar-Jiménez J, Martínez-Gálvez M, Ibáñez-Ibáñez MJ, Carrasco-González L, Gil-Izquierdo JI, Chaves-Benito MA, Ayala-De La Peña F, Nieto-Olivares A, Aguayo-Albasini JL. Flores-Funes D, et al. Among authors: ayala de la pena f. Surg Oncol. 2021 Sep;38:101636. doi: 10.1016/j.suronc.2021.101636. Epub 2021 Jul 21. Surg Oncol. 2021. PMID: 34303211
Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis.
Luengo-Gil G, González-Billalabeitia E, Chaves-Benito A, García Martínez E, García Garre E, Vicente V, Ayala de la Peña F. Luengo-Gil G, et al. Among authors: ayala de la pena f. Breast Cancer Res Treat. 2015 Jun;151(3):577-87. doi: 10.1007/s10549-015-3421-4. Epub 2015 May 13. Breast Cancer Res Treat. 2015. PMID: 25967462
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis.
García Garre E, Luengo Gil G, Montoro García S, Gonzalez Billalabeitia E, Zafra Poves M, García Martinez E, Roldán Schilling V, Navarro Manzano E, Ivars Rubio A, Lip GYH, Ayala de la Peña F. García Garre E, et al. Among authors: ayala de la pena f. Breast Cancer Res Treat. 2018 May;169(1):83-92. doi: 10.1007/s10549-017-4656-z. Epub 2018 Jan 16. Breast Cancer Res Treat. 2018. PMID: 29340882
48 results